For hæmodialysepatienter i end- stage- nyresygdom faldt AUC0- ∞ for total- aprepitant med 42% og Cmax faldt med 32%.
In patients with ESRD undergoing haemodialysis, the AUC0-∞ of total aprepitant decreased by 42% and Cmax decreased by 32%.